Strain identifier

BacDive ID: 14529

Type strain: Yes

Species: Staphylococcus epidermidis

Strain Designation: Fussel

Strain history: CIP <- 1981, J. Pillet, Inst. Pasteur, Garches, France <- ATCC <- Am. Meat Inst. Foundation, Chicago, USA: strain Fussel <- R. Deibel

NCBI tax ID(s): 1236978 (strain), 1282 (species)

« back to strain detail view
For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 8.1 (current version):
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 8.1 (current version)

General

@ref: 8450

BacDive-ID: 14529

DSM-Number: 20044

keywords: genome sequence, 16S sequence, Bacteria, facultative anaerobe, mesophilic, Gram-positive, human pathogen

description: Staphylococcus epidermidis Fussel is a facultative anaerobe, mesophilic, Gram-positive human pathogen that was isolated from nose.

NCBI tax id

NCBI tax idMatching level
1236978strain
1282species

strain history

@refhistory
8450<- CCM; CCM 2124 <- ATCC; ATCC 14990 <- AMIF; Fussel <- R. H. Deibel;
67770Y. Kosako <-- R. Sakazaki <-- ATCC 14990 <-- AMIF strain Fussel <-- R. Deibel.
119107CIP <- 1981, J. Pillet, Inst. Pasteur, Garches, France <- ATCC <- Am. Meat Inst. Foundation, Chicago, USA: strain Fussel <- R. Deibel

doi: 10.13145/bacdive14529.20230509.8.1

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/bacillota
  • domain: Bacteria
  • phylum: Bacillota
  • class: Bacilli
  • order: Caryophanales
  • family: Staphylococcaceae
  • genus: Staphylococcus
  • species: Staphylococcus epidermidis
  • full scientific name: Staphylococcus epidermidis (Winslow and Winslow 1908) Evans 1916 (Approved Lists 1980)

  • synonyms

    • @ref: 20215
    • synonym: Albococcus epidermidis

@ref: 8450

domain: Bacteria

phylum: Firmicutes

class: Bacilli

order: Bacillales

family: Staphylococcaceae

genus: Staphylococcus

species: Staphylococcus epidermidis

full scientific name: Staphylococcus epidermidis (Winslow and Winslow 1908) Evans 1916

strain designation: Fussel

type strain: yes

Morphology

cell morphology

@refgram stainconfidencecell shapemotility
69480positive100
119107positivecoccus-shapedno

colony morphology

@reftype of hemolysisincubation period
8450gamma1-2 days
119107

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
8450COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)yeshttps://mediadive.dsmz.de/medium/693Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base
8450TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)yeshttps://mediadive.dsmz.de/medium/92Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water
41796MEDIUM 72- for trypto casein soja agaryesDistilled water make up to (1000.000 ml);Trypto casein soy agar (40.000 g)
119107CIP Medium 72yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=72

culture temp

@refgrowthtypetemperaturerange
8450positivegrowth37mesophilic
41796positivegrowth37mesophilic
67770positivegrowth37mesophilic
119107positivegrowth37-45
119107nogrowth15psychrophilic

Physiology and metabolism

oxygen tolerance

  • @ref: 119107
  • oxygen tolerance: facultative anaerobe

antibiogram

@refmediumincubation temperatureoxygen conditionPenicillin Goxacillinampicillinticarcillinmezlocillincefalotincefazolincefotaximeaztreonamimipenemtetracyclinechloramphenicolgentamycinamikacinvancomycinerythromycinlincomycinofloxacinnorfloxacincolistinpipemidic acidnitrofurantoinbacitracinpolymyxin bkanamycinneomycindoxycyclineceftriaxoneclindamycinfosfomycinmoxifloxacinlinezolidnystatinquinupristin/dalfopristinteicoplaninpiperacillin/tazobactamincubation time
8450Mueller-Hinton Agar37aerob30383234-36304038360>5010-12343230223838-40323682030-3216-181430302032405038400321836
8450Mueller-Hinton Agar303830-323428-3038-4036-38340>50123228-303022343430-32341018321612302818-20324046-4836360321834
8450Mueller-Hinton Agar37aerob2436283026-283632340>50103228-3026-282032-3432-343032-34016-183016-181026242032-3438>503434-3603218341
8450Mueller-Hinton Agar3040323830-324238-40360>5012-1438-403230-322438-403634361020-2232-3420-221446282032-344248-503838-40036-3820-2236-38
8450Mueller-Hinton Agar37aerob324232-3440344640-4240-420>5010-12303232323434-36344018-2020321614-163230183638503838-40034-3622401
8450Mueller-Hinton Agar3714281214-161828242804061620-2216-1814-162216-1824-2628010-121810-128-102018-2012n.d.n.d.n.d.n.d.n.d.n.d.n.d.n.d.n.d.
8450Mueller-Hinton Agar37263826-283226-28403434-360>50123430302036-383632321018-2028-3016-1812-14302620n.d.n.d.n.d.n.d.n.d.n.d.n.d.n.d.n.d.
8450M 9237aerob32383238324040360>50123832302238-4038-403234-368203220123228203242503840-420342038
8450Mueller-Hinton Agar37aerob30383234-36304038360>5010-12343230223838-40323682030-3216-181430302032405038400321836
8450M 9237aerob32383238324040360>50123832302238-4038-403234-368203220123228203242503840-420342038

spore formation

@refspore formationconfidence
69481no97
69480no99.392

murein

  • @ref: 8450
  • murein short key: A11.03
  • type: A3alpha L-Lys-Gly2-4-L-Ser1-2-Gly

metabolite utilization

@refChebi-IDmetaboliteutilization activitykind of utilization tested
2294628757fructose+growth
2294617306maltose+growth
2294637684mannose+/-growth
2294633942ribose+growth
2294627082trehalose-growth
2294617992sucrose+growth
2294632528turanose+/-growth
11910717632nitrate+reduction
11910716301nitrite-reduction
6837516199urea+hydrolysis
6837529016arginine+hydrolysis
683754853esculin-hydrolysis
6837517634D-glucose+fermentation
6837515824D-fructose+fermentation
6837517306maltose+fermentation
6837517716lactose+fermentation
6837527082trehalose-fermentation
6837516899D-mannitol-fermentation
6837516634raffinose-fermentation
6837516988D-ribose-fermentation
6837517632nitrate+reduction
6837517992sucrose+fermentation
6837522599arabinose-fermentation
6837817634D-glucose+builds acid from
6837815824D-fructose+builds acid from
6837816024D-mannose+builds acid from
6837817306maltose+builds acid from
6837817716lactose+builds acid from
6837827082trehalose-builds acid from
6837816899D-mannitol-builds acid from
6837817151xylitol-builds acid from
6837828053melibiose-builds acid from
6837817632nitrate+reduction
6837816634raffinose-builds acid from
6837865327D-xylose-builds acid from
6837817992sucrose+builds acid from
68378320061methyl alpha-D-glucopyranoside-builds acid from
6837829016arginine+hydrolysis
6837816199urea+hydrolysis

metabolite production

@refChebi-IDmetaboliteproduction
6837815688acetoinyes
11910735581indoleno

metabolite tests

@refChebi-IDmetabolitevoges-proskauer-test
6837815688acetoin+
11910715688acetoin+

enzymes

@refvalueactivityec
8450catalase+1.11.1.6
8450cytochrome-c oxidase-1.9.3.1
68378urease+3.5.1.5
68378arginine dihydrolase+3.5.3.6
68378alkaline phosphatase+3.1.3.1
68375beta-glucuronidase-3.2.1.31
68375pyrrolidonyl arylamidase-3.4.19.3
68375L-arginine arylamidase-
68375beta-galactosidase-3.2.1.23
68375beta-glucosidase-3.2.1.21
68375arginine dihydrolase+3.5.3.6
68375urease+3.5.1.5
119107oxidase-
119107beta-galactosidase+3.2.1.23
119107alcohol dehydrogenase+1.1.1.1
119107gelatinase-
119107DNase-
119107catalase+1.11.1.6
119107coagulase-
119107lysine decarboxylase-4.1.1.18
119107ornithine decarboxylase-4.1.1.17
119107urease+3.5.1.5
68382alkaline phosphatase-3.1.3.1
68382esterase (C 4)-
68382esterase lipase (C 8)-
68382lipase (C 14)-
68382leucine arylamidase-3.4.11.1
68382valine arylamidase-
68382cystine arylamidase-3.4.11.3
68382trypsin-3.4.21.4
68382alpha-chymotrypsin-3.4.21.1
68382acid phosphatase-3.1.3.2
68382naphthol-AS-BI-phosphohydrolase-
68382alpha-galactosidase-3.2.1.22
68382beta-galactosidase-3.2.1.23
68382beta-glucuronidase-3.2.1.31
68382alpha-glucosidase-3.2.1.20
68382beta-glucosidase-3.2.1.21
68382N-acetyl-beta-glucosaminidase-3.2.1.52
68382alpha-mannosidase-3.2.1.24
68382alpha-fucosidase-3.2.1.51

API zym

@refControlAlkaline phosphataseEsteraseEsterase LipaseLipaseLeucine arylamidaseValine arylamidaseCystine arylamidaseTrypsinalpha- ChymotrypsinAcid phosphataseNaphthol-AS-BI-phosphohydrolasealpha- Galactosidasebeta- Galactosidasebeta- Glucuronidasealpha- Glucosidasebeta- GlucosidaseN-acetyl-beta- glucosaminidasealpha- Mannosidasealpha- Fucosidase
119107--------------------

API ID32STA

@refUREADH ArgODCESCGLUFRUMNEMALLACTREMANRAFRIBCELNITVPbeta GALArgAPALPyrANOVOSACNAGTURARAbeta GUR
8450++--+++++-----++--+--+-+--
8450++--++-++-----++--+--+-+--
8450++--+++++-----++-----+-+/---
8450++--+++++-----++--+-++-+--
8450++--+++++-----++--+-+/-+----
8450++--+++++-----++--+--+-+--
8450++--+++++----++---+/--++-+--
8450++--+++++-----++--+-+/-+----
8450+++/--++-++-----++--+--+-+/---
8450++--+++++-----+--+-++++--
8450++--++-++-----++--+--+-+--

API STA

@refControlGLUFRUMNEMALLACTREMANXLTMELNITPALVPRAFXYLSACMDGNAGADHURE
8450-+++++----+++--+-+/-++

API biotype100

@refGLUFRUGALTREMNESBEMELSACRAFMTEMALLACLTEMbGaMaGaCELGENMbGuESCRIBARAXYLPLERHAFUCMLZDARLLARLXLTDULTAGGLYINOMANMTLTURSORADOHBGLYXERYMDG3MDGSATMUCLTATDTATMTATDMLTLMLTCATETATETTECITGRTGAT2KG5KGTRYNAGGNTPACPATpOBEQATGTEmOBEBATPPATCMTTGEBETPCEABTHINLATCAPCYTHISSUCFUMGREGYTAVTETNTTNGLNITA3OBUAPTGTTPRODALALALASERMNTPROPTYR2KT
119107---------------------------------------------------------------------------------------------------

Isolation, sampling and environmental information

isolation

@refsample type
8450nose
67770Nose
119107Nasal swab

isolation source categories

  • Cat1: #Host Body-Site
  • Cat2: #Organ
  • Cat3: #Nose

taxonmaps

  • @ref: 69479
  • File name: preview.99_86.png
  • url: https://microbeatlas.org/index.html?action=taxon&taxon_id=90_3;96_3;97_3;98_3;99_86&stattab=map
  • Last taxonomy: Staphylococcus
  • 16S sequence: LN681574
  • Sequence Identity:
  • Total samples: 8633
  • soil counts: 44
  • aquatic counts: 284
  • animal counts: 8287
  • plant counts: 18

Safety information

risk assessment

@refpathogenicity humanpathogenicity animalbiosafety levelbiosafety level comment
8450yesyes2Risk group (German classification)
1191071Risk group (French classification)

Sequence information

16S sequences

@refdescriptionaccessionlengthdatabaseNCBI tax ID
20218Staphylococcus epidermidis strain DSM 20044 16S ribosomal RNA gene, partial sequenceAY688053464ena1282
20218Staphylococcus epidermidis 16S ribosomal RNA (16S rRNA) geneL376051468ena1282
20218Staphylococcus epidermidis ATCC 14990 16S rRNA gene, partial sequenceU02913397ena1282
20218S.epidermidis gene for 16S ribosomal RNAZ26894771ena1282
8450Staphylococcus epidermidis gene for 16S rRNA, partial sequence, strain: ATCC 14990D833631475ena1282
8450Staphylococcus epidermidis partial 16S rRNA gene, type strain DSM 20044TLN6815741503ena1282

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Staphylococcus epidermidis ATCC 14990GCA_006094375completencbi1282
66792Staphylococcus epidermidis NBRC 100911GCA_006742205completencbi1282
66792Staphylococcus epidermidis JCM 24141236978.3wgspatric1236978
66792Staphylococcus epidermidis strain ATCC 149901282.2210wgspatric1282
66792Staphylococcus epidermidis strain ATCC 149901282.2319plasmidpatric1282
66792Staphylococcus epidermidis strain ATCC 149901282.3288completepatric1282
66792Staphylococcus epidermidis strain NBRC 1009111282.3359wgspatric1282
66792Staphylococcus epidermidis strain NCTC 110471282.2421wgspatric1282
66792Staphylococcus epidermidis strain NCTC110471282.2825wgspatric1282
66792Staphylococcus epidermidis JCM 24142728369663draftimg1236978
67770Staphylococcus epidermidis JCM 2414GCA_001310935contigncbi1236978
67770Staphylococcus epidermidis ATCC 14990GCA_002087975scaffoldncbi1282
67770Staphylococcus epidermidis NCTC 11047GCA_002901875scaffoldncbi1282
67770Staphylococcus epidermidis NCTC11047GCA_900458605contigncbi1282

GC content

@refGC-contentmethod
845034.6
6777033.5thermal denaturation, midpoint method (Tm)

Genome-based predictions

predictions

traitpredictionconfidencetraining_data
spore-formingno97no
motileno91.44no
flagellatedno91.261no
gram-positiveyes91.23no
anaerobicno98.834no
aerobicyes86.359no
halophileyes95.275no
spore-formingno92.126no
thermophileno99.825no
glucose-utilyes90.954no
glucose-fermentyes80.361no

External links

@ref: 8450

culture collection no.: DSM 20044, ATCC 14990, CCM 2124, WDCM 00132, JCM 2414, CCUG 18000, CCUG 39508, CECT 232, CIP 81.55, IAM 12013, LMG 10474, NBRC 100865, NBRC 100911, NCIMB 12721, NCTC 11047

straininfo link

  • @ref: 83660
  • straininfo: 92435

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Enzymology242300Purification and properties of a fructose-1,6-diphosphate activated L-lactate dehydrogenase from Staphylococcus epidermidis.Gotz F, Schleifer KHArch Microbiol10.1007/BF004471501975Adenine Nucleotides/pharmacology, Drug Stability, Enzyme Activation/drug effects, Fructosephosphates/metabolism, Hydrogen-Ion Concentration, Kinetics, L-Lactate Dehydrogenase/*analysis/antagonists & inhibitors/isolation & purification, Lactates, Molecular Weight, NAD, Oxamic Acid/pharmacology, Pyruvates/metabolism, Staphylococcus/*enzymology, Stereoisomerism, TemperatureMetabolism
Pathogenicity2232143[Antibacterial activity of local anesthetics].Noda H, Saionji K, Miyazaki TMasui1990Anesthetics, Local/*pharmacology, Bacteria/*drug effects, Bupivacaine/pharmacology, Lidocaine/pharmacology
Pathogenicity2459099Azelaic acid: its uptake and mode of action in Staphylococcus epidermidis NCTC 11047.Bojar RA, Holland KT, Leeming JP, Cunliffe WJJ Appl Bacteriol10.1111/j.1365-2672.1988.tb02441.x1988Carbon Radioisotopes, Culture Media/pharmacology, DNA/biosynthesis, Dicarboxylic Acids/*pharmacokinetics/pharmacology, Hydrogen-Ion Concentration, Oxygen Consumption/drug effects, Protein Biosynthesis, RNA/biosynthesis, Staphylococcus epidermidis/drug effects/growth & development/*metabolismCultivation
Pathogenicity2516858Nisin inhibits several gram-positive, mastitis-causing pathogens.Broadbent JR, Chou YC, Gillies K, Kondo JKJ Dairy Sci10.3168/jds.S0022-0302(89)79496-01989Animals, Cattle, Colony Count, Microbial, Enterococcus faecalis/drug effects, Escherichia coli/*drug effects, Mastitis, Bovine/*microbiology, Microbial Sensitivity Tests, Milk/microbiology, Nisin/*pharmacology, Staphylococcus/*drug effects, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects, Streptococcus/*drug effects, Streptococcus agalactiae/drug effects
Pathogenicity3700616Enzyme-linked immunosorbent assay for detection of Staphylococcus epidermidis antibody in experimental S. epidermidis endocarditis.Espersen F, Wheat LJ, Bemis AT, White AJ Clin Microbiol10.1128/jcm.23.2.339-342.19861986Animals, Antibodies, Bacterial/*analysis/biosynthesis, Antibody Specificity, Antigens, Bacterial, Diagnosis, Differential, Endocarditis, Bacterial/diagnosis/*immunology, Enzyme-Linked Immunosorbent Assay, Humans, Rabbits, Sepsis/diagnosis/immunology, Staphylococcal Infections/*immunology, Staphylococcus epidermidis/*immunologyEnzymology
Pathogenicity6379573[Verification of the effectiveness of neutralization in the in vivo study of antiseptics].Reverdy ME, Martra A, Fleurette JPathol Biol (Paris)1984Anti-Infective Agents, Local/*antagonists & inhibitors, Bacteriological Techniques, Humans, Neutralization Tests/methods, Staphylococcus epidermidis/drug effects
Cultivation6464568Colony-formation of staphylococci in fibronectin-soft-agar.Lammler C, Blobel HZentralbl Bakteriol Mikrobiol Hyg A1984*Agar, Blood, Culture Media, Fibrinogen, *Fibronectins, Staphylococcus aureus/*growth & development, Staphylococcus epidermidis/*growth & development
Phylogeny6735981Secondary structure and phylogeny of Staphylococcus and Micrococcus 5S rRNAs.Dekio S, Yamasaki R, Jidoi J, Hori H, Osawa SJ Bacteriol10.1128/jb.159.1.233-237.19841984Base Sequence, Micrococcus/*genetics, Molecular Weight, Nucleic Acid Conformation, *Phylogeny, RNA, Ribosomal/*genetics/isolation & purification, Species Specificity, Staphylococcus aureus/*genetics, Staphylococcus epidermidis/*geneticsEnzymology
Pathogenicity7546647Comparison of adherent and non-adherent staphylococci in the induction of polymorphonuclear leukocyte activation in vitro.Riber U, Espersen F, Kharazmi AAPMIS10.1111/j.1699-0463.1995.tb01130.x1995*Bacterial Adhesion, Complement System Proteins/physiology, Humans, Luminescent Measurements, Neutrophils/*physiology, Phagocytosis, Staphylococcus/immunology/*physiology, Superoxides/metabolismMetabolism
Metabolism7629853Adhesion of staphylococci to polyurethane and hydrogel-coated polyurethane catheters assayed by an improved radiolabelling technique.John SF, Hillier VF, Handley PS, Derrick MRJ Med Microbiol10.1099/00222615-43-2-1331995Analysis of Variance, *Bacterial Adhesion, Catheterization, Central Venous, Catheterization, Peripheral, Catheters, Indwelling, Colony Count, Microbial, Humans, Hydrogel, Polyethylene Glycol Dimethacrylate, *Polyethylene Glycols/metabolism, *Polyurethanes/metabolism, Reproducibility of Results, Staphylococcus aureus/*metabolism, Staphylococcus epidermidis/*metabolism, Surface PropertiesPathogenicity
Enzymology7768789Characterization of the gene for the chromosomal dihydrofolate reductase (DHFR) of Staphylococcus epidermidis ATCC 14990: the origin of the trimethoprim-resistant S1 DHFR from Staphylococcus aureus?Dale GE, Broger C, Hartman PG, Langen H, Page MG, Then RL, Stuber DJ Bacteriol10.1128/jb.177.11.2965-2970.19951995Amino Acid Sequence, Base Sequence, Cloning, Molecular, DNA Transposable Elements, Drug Resistance, Microbial, *Genes, Bacterial, Kinetics, Models, Molecular, Molecular Sequence Data, Mutagenesis, Site-Directed, Sequence Alignment, Sequence Homology, Amino Acid, Staphylococcus aureus/*genetics, Staphylococcus epidermidis/*genetics, Structure-Activity Relationship, Tetrahydrofolate Dehydrogenase/*geneticsGenetics
Metabolism7894712Staphylococcus aureus but not Staphylococcus epidermidis can acquire iron from transferrin.Lindsay JA, Riley TV, Mee BJMicrobiology (Reading)10.1099/00221287-141-1-1971995Biological Transport, Humans, Iron/*metabolism, Iron Radioisotopes, Kinetics, Metalloendopeptidases/metabolism, Species Specificity, Staphylococcus aureus/growth & development/*metabolism, Staphylococcus epidermidis/growth & development/*metabolism, Time Factors, Transferrin/*metabolismPathogenicity
Pathogenicity8384459Induction of oxidative burst response in human neutrophils by adherent staphylococci. Comparison between Staphylococcus epidermidis and Staphylococcus aureus.Riber U, Espersen F, Skinhoj P, Kharazmi AAPMIS10.1111/j.1699-0463.1993.tb00081.x1993Humans, In Vitro Techniques, Kinetics, Neutrophils/microbiology/*physiology, Species Specificity, Staphylococcus aureus/*physiology, Staphylococcus epidermidis/*physiology, Superoxides/*blood, Time FactorsEnzymology
Phylogeny8605069Quantification of the ease of removal of bacteria from surfaces.Eginton PJ, Gibson H, Holah J, Handley PS, Gilbert PJ Ind Microbiol10.1007/BF015699841995*Bacteria, Bacterial Adhesion/*physiology, *Biofilms, Colony Count, Microbial, Escherichia coli, *Glass, Hygiene, *Plastics, Pseudomonas aeruginosa, Species Specificity, *Stainless Steel, Staphylococcus epidermidis
Pathogenicity9465710[Adherence of staphylococci of different hydrophobicity. Study of various intraocular lenses].Schloricke E, Schmidt H, Schulze HA, Beck R, Guthoff R, Falkenhagen UOphthalmologe10.1007/s0034700502041997Bacterial Adhesion/*physiology, Endophthalmitis/microbiology, Humans, Lenses, Intraocular/*microbiology, Polymethyl Methacrylate, Prosthesis Design, Silicone Elastomers, Staphylococcus epidermidis/*physiology, Surface Properties, Surgical Wound Infection/microbiology
Enzymology9532272Effect of surface modifications of intraocular lenses on the adherence of Staphylococcus epidermidis.Schmidt H, Schloricke E, Fislage R, Schulze HA, Guthoff RZentralbl Bakteriol10.1016/s0934-8840(98)80159-x1998Bacterial Adhesion/genetics/*physiology, Electrophoresis, Gel, Pulsed-Field, *Lenses, Intraocular, Polymethyl Methacrylate/analysis, Silicones/analysis, Staphylococcus epidermidis/genetics/isolation & purification/*physiology, Surface PropertiesPhylogeny
Phylogeny9765856Identification of atypical strains of Staphylococcus epidermidis by use of molecular tools.Riou C, Meugnier H, Bes M, Brun Y, Fiedler F, Lasne Y, Etienne J, Freney JRes Microbiol10.1016/S0923-2508(99)80070-91997Amino Acids/analysis, Atypical Bacterial Forms/chemistry/*classification/isolation & purification, *Bacterial Typing Techniques, Cell Wall/chemistry, DNA, Ribosomal/analysis, Genotype, Humans, *Molecular Probe Techniques, Peptidoglycan/chemistry, Phenotype, Phosphorus/analysis, RNA, Ribosomal, 16S/classification/genetics, Staphylococcus epidermidis/chemistry/*classification/isolation & purificationEnzymology
Enzymology10648531Molecular analysis of the tagF gene, encoding CDP-Glycerol:Poly(glycerophosphate) glycerophosphotransferase of Staphylococcus epidermidis ATCC 14990.Fitzgerald SN, Foster TJJ Bacteriol10.1128/JB.182.4.1046-1052.20002000Amino Acid Sequence, Bacillus subtilis/genetics, Blotting, Western, Chromosome Mapping, Cloning, Molecular, Electrophoresis, Polyacrylamide Gel, Genetic Complementation Test, Molecular Sequence Data, Plasmids/genetics, Sequence Analysis, DNA, Staphylococcus epidermidis/*enzymology/*genetics, Teichoic Acids/metabolism, Transferases (Other Substituted Phosphate Groups)/chemistry/*genetics/metabolism, Transformation, BacterialGenetics
Enzymology11064268Identification of a novel antigen from Staphylococcus epidermidis.Lang S, Livesley MA, Lambert PA, Littler WA, Elliott TSFEMS Immunol Med Microbiol10.1111/j.1574-695X.2000.tb01525.x2000Amino Acid Sequence, Blotting, Western, DNA, Bacterial/analysis, Electrophoresis, Polyacrylamide Gel, Endocarditis, Bacterial/immunology/*microbiology, Gene Library, Humans, Molecular Sequence Data, Polymerase Chain Reaction, Ribonucleoproteins/genetics/*isolation & purification, Sequence Alignment, Staphylococcal Infections/immunology/*microbiology, Staphylococcus epidermidis/*immunology/isolation & purificationPathogenicity
Pathogenicity11463527Elucidation of antibiotic effectiveness against Staphylococcus epidermidis during intraocular lens implantation.Kadry AA, Tawfik AF, Abu El-Asrar AA, Shibl AMInt J Antimicrob Agents10.1016/s0924-8579(01)00338-72001Anti-Bacterial Agents/*pharmacology, Antibiotic Prophylaxis, Bacterial Adhesion/*drug effects, Ciprofloxacin/pharmacology, Clindamycin/pharmacology, Conjunctiva/microbiology, Endophthalmitis/prevention & control, Epithelial Cells/*microbiology, Gentamicins/pharmacology, Humans, *Lens Implantation, Intraocular, Lenses, Intraocular/*microbiology, Microbial Sensitivity Tests, Postoperative Complications/prevention & control, Staphylococcal Infections/prevention & control, Staphylococcus epidermidis/*drug effects/physiology, Vancomycin/pharmacology
Enzymology12127798Characterization and molecular cloning of a glutamyl endopeptidase from Staphylococcus epidermidis.Ohara-Nemoto Y, Ikeda Y, Kobayashi M, Sasaki M, Tajika S, Kimura SMicrob Pathog10.1006/mpat.2002.05152002Amino Acid Sequence, Amino Acids/analysis, Base Sequence, Cloning, Molecular, DNA, Bacterial/analysis, Escherichia coli/genetics, Metalloendopeptidases/genetics/metabolism, Molecular Sequence Data, Sequence Homology, Amino Acid, Serine Endopeptidases/*genetics/metabolism, Staphylococcus epidermidis/*enzymology/geneticsMetabolism
Pathogenicity12599021Granulocyte colony-stimulating factor for the treatment of biomaterial-associated staphylococcal infections in-vitro.Schlobe A, Schnitzler N, Schweizer K, Rohde DUrol Res10.1007/s00240-002-0289-72002Adult, Granulocyte Colony-Stimulating Factor/*pharmacology, Humans, In Vitro Techniques, Microspheres, Neutrophil Activation/drug effects, Neutrophils/immunology/microbiology, Phagocytosis/*drug effects, Recombinant Proteins/pharmacology, Staphylococcal Infections/*drug therapy/immunology, *Staphylococcus epidermidis
Metabolism16187057Rapid decrease of free vancomycin in dense staphylococcal cultures.Ekdahl C, Hanberger H, Hallgren A, Nilsson M, Svensson E, Nilsson LEEur J Clin Microbiol Infect Dis10.1007/s10096-005-0011-02005Adenosine Triphosphate/metabolism, Anti-Bacterial Agents/metabolism/pharmacology, Colony Count, Microbial, Humans, In Vitro Techniques, Luminescence, Staphylococcal Infections/drug therapy, Staphylococcus aureus/drug effects/*metabolism, Staphylococcus epidermidis/drug effects/*metabolism, Vancomycin/*metabolism/pharmacology, Vancomycin ResistancePathogenicity
Metabolism17277069Localized tufts of fibrils on Staphylococcus epidermidis NCTC 11047 are comprised of the accumulation-associated protein.Banner MA, Cunniffe JG, Macintosh RL, Foster TJ, Rohde H, Mack D, Hoyes E, Derrick J, Upton M, Handley PSJ Bacteriol10.1128/JB.00952-062007Bacterial Proteins/*metabolism, Cell Membrane/metabolism, DNA Primers, Humans, Polymerase Chain Reaction, Recombinant Fusion Proteins/metabolism, Skin/microbiology, Staphylococcus epidermidis/*metabolism/ultrastructurePathogenicity
Pathogenicity17703097Proinflammatory impact of Staphylococcus epidermidis on the nasal epithelium quantified by IL-8 and GRO-alpha responses in primary human nasal epithelial cells.Sachse F, von Eiff C, Becker K, Steinhoff M, Rudack CInt Arch Allergy Immunol10.1159/0001074632007Cell Line, Cells, Cultured, Chemokine CXCL1/*immunology, Chronic Disease, Epithelial Cells/immunology/microbiology, Humans, Interleukin-6/immunology, Interleukin-8/*immunology, NF-kappa B/antagonists & inhibitors, Nasal Mucosa/cytology/*immunology, Nasal Polyps/immunology/microbiology, Nitriles/pharmacology, Rhinitis/immunology/*microbiology, Serine Proteinase Inhibitors/pharmacology, Sinusitis/immunology/*microbiology, Staphylococcus epidermidis/*immunology/isolation & purification, Sulfones/pharmacologyEnzymology
Pathogenicity18708273Synthesis, characterization and antibacterial activity of some triazole Mannich bases carrying diphenylsulfone moieties.Almajan GL, Barbuceanu SF, Almajan ER, Draghici C, Saramet GEur J Med Chem10.1016/j.ejmech.2008.07.0032008Anti-Bacterial Agents/*chemical synthesis/chemistry/*pharmacology, Bacteria/*drug effects, Mannich Bases/*chemistry, Microbial Sensitivity Tests, Sulfones/*chemistry, Triazoles/*chemical synthesis/chemistry/*pharmacology
Pathogenicity19356828Copper(II) and uranyl(II) complexes with acylthiosemicarbazide: synthesis, characterization, antibacterial activity and effects on the growth of promyelocytic leukemia cells HL-60.Angelusiu MV, Almajan GL, Rosu T, Negoiu M, Almajan ER, Roy JEur J Med Chem10.1016/j.ejmech.2009.03.0162009Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Antineoplastic Agents/chemical synthesis/chemistry/pharmacology, Bacteria/*drug effects, Cell Proliferation/drug effects, Cell Survival/drug effects, Copper/*chemistry, Electron Spin Resonance Spectroscopy, Electrons, HL-60 Cells, Humans, Leukemia/*pathology, Ligands, Magnetics, Organometallic Compounds/chemical synthesis/*chemistry/*pharmacology, Semicarbazides/*chemistry, Spectrophotometry, Infrared, Thermogravimetry, Uranium/*chemistry
Pathogenicity19616347Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.Barbuceanu SF, Almajan GL, Saramet I, Draghici C, Tarcomnicu AI, Bancescu GEur J Med Chem10.1016/j.ejmech.2009.06.0212009Anti-Bacterial Agents/*chemistry/*pharmacology, Bacteria/drug effects, Biphenyl Compounds/chemistry/pharmacology, Microbial Sensitivity Tests, Molecular Structure, Structure-Activity Relationship, Sulfones/*chemistry/*pharmacology, Triazoles/*chemistry/*pharmacology
Metabolism19749046The terminal A domain of the fibrillar accumulation-associated protein (Aap) of Staphylococcus epidermidis mediates adhesion to human corneocytes.Macintosh RL, Brittan JL, Bhattacharya R, Jenkinson HF, Derrick J, Upton M, Handley PSJ Bacteriol10.1128/JB.00764-092009Bacterial Adhesion/genetics/*physiology, Bacterial Proteins/*chemistry/genetics/metabolism/*physiology, Blotting, Western, Cells, Cultured, Epidermal Cells, Epidermis/*microbiology/ultrastructure, Flow Cytometry, Humans, Lactococcus lactis/genetics/metabolism/*physiology/ultrastructure, Microscopy, Electron, Transmission, Staphylococcus epidermidis/genetics/*metabolism/*physiology/ultrastructurePathogenicity
Pathogenicity20307919New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation.Almajan GL, Barbuceanu SF, Saramet I, Draghici CEur J Med Chem10.1016/j.ejmech.2010.02.0572010Anti-Bacterial Agents/chemical synthesis/*chemistry/*pharmacology, Bacteria/*drug effects, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Spectrophotometry, Infrared, Thiadiazines/chemical synthesis/*chemistry/*pharmacology
Pathogenicity20727993Towards long-lasting antibacterial stainless steel surfaces by combining double glow plasma silvering with active screen plasma nitriding.Dong Y, Li X, Tian L, Bell T, Sammons RL, Dong HActa Biomater10.1016/j.actbio.2010.08.0092010Alloys/chemistry, Anti-Bacterial Agents/*pharmacology, Bacteria/drug effects/growth & development, Colony Count, Microbial, Hardness/drug effects, Hydrophobic and Hydrophilic Interactions/drug effects, Materials Testing/*methods, Microbial Sensitivity Tests, Microscopy, Electron, Scanning, Nitrogen/*chemistry, Plasma Gases/*chemistry, Silver/*chemistry, Stainless Steel/*pharmacology, Surface Properties/drug effects, Thermodynamics, X-Ray Diffraction
Pathogenicity21315368Titania-silver and alumina-silver composite nanoparticles: novel, versatile synthesis, reaction mechanism and potential antimicrobial application.Bala T, Armstrong G, Laffir F, Thornton RJ Colloid Interface Sci10.1016/j.jcis.2011.01.0442011Aluminum Oxide/*chemistry/pharmacology, Anti-Bacterial Agents/*chemistry/pharmacology, Escherichia coli/drug effects, Escherichia coli Infections/drug therapy, Humans, Nanoparticles/*chemistry/ultrastructure, Silver/*chemistry/pharmacology, Staphylococcal Infections/drug therapy, Staphylococcus epidermidis/drug effects, Titanium/*chemistry/pharmacology
Pathogenicity21528775In vitro study of antibacterial activity of the alga Sargassum oligocystum from the Persian Gulf.Tajbakhsh S, Pouyan M, Zandi K, Bahramian P, Sartavi K, Fouladvand M, Asayesh G, Barazesh AEur Rev Med Pharmacol Sci2011Anti-Bacterial Agents/isolation & purification/*pharmacology, Escherichia coli/drug effects/growth & development, Indian Ocean, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/growth & development, Sargassum/*chemistry, Seawater, Staphylococcus aureus/drug effects/growth & development, Staphylococcus epidermidis/drug effects/growth & developmentEnzymology
Pathogenicity22684972Comparison of microplate and macrodilution methods in time-kill study of new antimicrobial drugs.Zhou Y, Hou Z, Fang C, Xue X, Da F, Wang Y, Bai H, Luo XFolia Microbiol (Praha)10.1007/s12223-012-0168-82012Anti-Infective Agents/*pharmacology, Escherichia coli/drug effects, Microbial Sensitivity Tests/*methods, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects
Pathogenicity22713942Antimicrobial activities of Aerva javanica and Paeonia emodi plants.Mufti FU, Ullah H, Bangash A, Khan N, Hussain S, Ullah F, Jamil M, Jabeen MPak J Pharm Sci2012*Amaranthaceae, Anti-Bacterial Agents/*pharmacology, Antifungal Agents/*pharmacology, Aspergillus/drug effects, Escherichia coli/drug effects, Methicillin-Resistant Staphylococcus aureus/drug effects, Microbial Sensitivity Tests, *Paeonia, Plant Extracts/*pharmacology, Pseudomonas aeruginosa/drug effects
Pathogenicity24258612Mineralogical variables that control the antibacterial effectiveness of a natural clay deposit.Morrison KD, Underwood JC, Metge DW, Eberl DD, Williams LBEnviron Geochem Health10.1007/s10653-013-9585-02013Aluminum/pharmacology, Aluminum Silicates/*chemistry/*pharmacology, Anti-Bacterial Agents/*pharmacology, Cations/chemistry, Clay, Escherichia coli/drug effects, Hydrogen-Ion Concentration, Iron/analysis/pharmacology, Microbial Sensitivity Tests, Microscopy, Electron, Scanning Transmission, Minerals/analysis, Oregon, Oxidation-Reduction, Staphylococcus epidermidis/drug effects, Sulfides, X-Ray Diffraction
Pathogenicity24506719[Investigation of antimicrobial and antibiofilm effects of some preservatives used in drugs, cosmetics and food products].Guven N, Kaynak Onurdag FMikrobiyol Bul2014Anti-Infective Agents/*pharmacology, Bacteria/drug effects, Biofilms/*drug effects, Candida albicans/drug effects/physiology, Cosmetics/*chemistry, Food Preservatives/*pharmacology, Glass, Hydrogen-Ion Concentration, Microbial Sensitivity Tests, Preservatives, Pharmaceutical/*pharmacology
Pathogenicity26146655Antimicrobial Analysis of an Antiseptic Made from Ethanol Crude Extracts of P. granatum and E. uniflora in Wistar Rats against Staphylococcus aureus and Staphylococcus epidermidis.Bernardo TH, Sales Santos Verissimo RC, Alvino V, Silva Araujo MG, Evangelista Pires dos Santos RF, Mauricio Viana MD, de Assis Bastos ML, Alexandre-Moreira MS, de Araujo-Junior JXScientificWorldJournal10.1155/2015/7517912015Animals, Anti-Bacterial Agents/administration & dosage/*pharmacology, Disease Models, Animal, Female, Lythraceae/*chemistry, Microbial Sensitivity Tests, Plant Extracts/administration & dosage/*pharmacology, Rats, Staphylococcal Infections/drug therapy/*microbiology, Staphylococcus aureus/*drug effects, Staphylococcus epidermidis/*drug effects
Pathogenicity26393571Synthesis of Biscoumarin and Dihydropyran Derivatives and Evaluation of Their Antibacterial Activity.Li J, Lv CW, Li XJ, Qu D, Hou Z, Jia M, Luo XX, Li X, Li MKMolecules10.3390/molecules2009174692015Anti-Bacterial Agents/*chemical synthesis/pharmacology, Coumarins/chemical synthesis/*pharmacology, Crystallography, X-Ray, Hydrogen Bonding, Methicillin-Resistant Staphylococcus aureus/drug effects, Molecular Structure, Pyrans/chemical synthesis/*pharmacology, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects
Genetics28684584Draft Genome Sequence of Staphylococcus epidermidis (Winslow and Winslow) Evans (ATCC 14990).Putonti C, Kalesinskas L, Cudone E, Engelbrecht KC, Koenig DW, Wolfe AJGenome Announc10.1128/genomeA.00619-172017
28929050Synergistic effect of Carum copticum and Mentha piperita essential oils with ciprofloxacin, vancomycin, and gentamicin on Gram-negative and Gram-positive bacteria.Talei GR, Mohammadi M, Bahmani M, Kopaei MRInt J Pharm Investig10.4103/jphi.JPHI_12_172017
Enzymology29155275Antibacterial compounds from the Australian native plant Eremophila glabra.Algreiby AA, Hammer KA, Durmic Z, Vercoe P, Flematti GRFitoterapia10.1016/j.fitote.2017.11.0082017Anti-Bacterial Agents/*chemistry/isolation & purification, Diterpenes/*chemistry/isolation & purification, Flavonoids/*chemistry/isolation & purification, Microbial Sensitivity Tests, Molecular Structure, Plant Extracts/chemistry, Plant Leaves/chemistry, Scrophulariaceae/*chemistry, Secondary Metabolism, Western AustraliaPhylogeny
Pathogenicity30317865Antimicrobial activity of spices essential oils and its effectiveness on mature biofilms of human pathogens.Condo C, Anacarso I, Sabia C, Iseppi R, Anfelli I, Forti L, de Niederhausern S, Bondi M, Messi PNat Prod Res10.1080/14786419.2018.14909042018Anti-Bacterial Agents/isolation & purification/*pharmacology, Biofilms/*drug effects, Candida albicans/drug effects, Cinnamomum zeylanicum/chemistry, Cuminum/chemistry, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Humans, Microbial Sensitivity Tests, Oils, Volatile/*pharmacology/therapeutic use, Pseudomonas aeruginosa/drug effects, *Spices, Syzygium/chemistryEnzymology
31581500Influence of Short Cationic Lipopeptides with Fatty Acids of Different Chain Lengths on Bacterial Biofilms Formed on Polystyrene and Hydrogel Surfaces.Paduszynska MA, Maciejewska M, Neubauer D, Golacki K, Szymukowicz M, Bauer M, Kamysz WPharmaceutics10.3390/pharmaceutics111005062019
Pathogenicity31759094Do pneumatic tube transport systems transmit potential pathogens? A hygienic risk assessment in a university hospital.Khaznadar L, Dancer SJ, Petersmann A, Seifert U, Below H, Papke R, Suchomel M, Kohlmann T, Kramer AJ Hosp Infect10.1016/j.jhin.2019.11.0092019Cross Infection/*prevention & control, Disease Outbreaks/*prevention & control, *Equipment Contamination, Hospitals, University, Humans, *Hygiene, Risk Assessment
32903580Inhibition of Neutrophil Functions and Antibacterial Effects of Tarragon (Artemisia dracunculus L.) Infusion-Phytochemical Characterization.Majdan M, Kiss AK, Halasa R, Granica S, Osinska E, Czerwinska MEFront Pharmacol10.3389/fphar.2020.009472020
34438944Facile Green, Room-Temperature Synthesis of Gold Nanoparticles Using Combretum erythrophyllum Leaf Extract: Antibacterial and Cell Viability Studies against Normal and Cancerous Cells.Fanoro OT, Parani S, Maluleke R, Lebepe TC, Varghese JR, Mavumengwana V, Oluwafemi OSAntibiotics (Basel)10.3390/antibiotics100808932021
34827214Biosynthesis of Smaller-Sized Platinum Nanoparticles Using the Leaf Extract of Combretum erythrophyllum and Its Antibacterial Activities.Fanoro OT, Parani S, Maluleke R, Lebepe TC, Varghese RJ, Mgedle N, Mavumengwana V, Oluwafemi OSAntibiotics (Basel)10.3390/antibiotics101112752021
35579741Promising Endophytic Alternaria alternata from Leaves of Ziziphus spina-christi: Phytochemical Analyses, Antimicrobial and Antioxidant Activities.Elghaffar RYA, Amin BH, Hashem AH, Sehim AEAppl Biochem Biotechnol10.1007/s12010-022-03959-92022
Pathogenicity35967335Monoclonal antibodies effectively potentiate complement activation and phagocytosis of Staphylococcus epidermidis in neonatal human plasma.de Vor L, Beudeker CR, Flier A, Scheepmaker LM, Aerts PC, Vijlbrief DC, Bekker MN, Beurskens FJ, van Kessel KPM, de Haas CJC, Rooijakkers SHM, van der Flier MFront Immunol10.3389/fimmu.2022.9332512022Adult, Antibodies, Monoclonal/pharmacology, *Antineoplastic Agents, Immunological, Complement Activation, Humans, Immunoglobulins, Intravenous, Infant, Newborn, Phagocytosis, *Staphylococcus epidermidis
36061130A New Specific DNA Target Sequence for Identification of Staphylococcus epidermidis using Modified Comparative Genomic Analysis.Khoshbakht R, Zare H, Kamali Kakhki R, Neshani A, Arfaatabar MAvicenna J Med Biotechnol10.18502/ajmb.v14i3.98282022

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
8450Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 20044)https://www.dsmz.de/collection/catalogue/details/culture/DSM-20044
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
22946L. A. DEVRIESE, B. POUTREL, R. KILPPER-BÄLZ, K. H. SCHLEIFER10.1099/00207713-33-3-480Staphylococcus gallinarum and Staphylococcus caprae, Two New Species from AnimalsIJSEM 33: 480-486 1983
41796Curators of the CIPhttps://brclims.pasteur.fr/brcWeb/souche/detail/1/11218
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
67770Curators of the JCMhttps://jcm.brc.riken.jp/en/
68375Automatically annotated from API ID32STA
68378Automatically annotated from API STA
68382Automatically annotated from API zym
69479João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.https://microbeatlas.org/MicrobeAtlas 1.0 beta
69480Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesPredictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
69481Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch10.21203/rs.3.rs-2527258/v1Predictions based on the model GenomeNet Sporulation v. 1
83660Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.10.60712/SI-ID92435.1StrainInfo: A central database for resolving microbial strain identifiers
119107Curators of the CIPCollection of Institut Pasteur (CIP 81.55)https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2081.55